International Journal of Hematology

DOI: 10.1007/s12185-018-2403-9 Pages: 395-404

Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial

1. Gachon University Gil Medical Center, Division of Hematology, Department of Internal Medicine

2. National Cancer Center, Center for Hematologic Malignancy

3. University of Ulsan College of Medicine, Department of Oncology, Asan Medical Center

Correspondence to:
Cheolwon Suh
Tel: +82-2-3010-3209



Lymphomas are a heterogeneous group of disease entities with well-defined clinical, morphological, immunophenotypic, and cytogenetic characteristics. Moreover, regional and racial differences have been reported in their incidence and subtype compositions. Here, we reviewed the epidemiology of lymphomas and summarized the recent achievements in specific subtypes prevalent in Korean population, focusing on clinical studies conducted by the Consortium for Improving Survival of Lymphoma (CISL) of the Korean Society of Hematology Lymphoma Working Party (KSH-LWP).

This article is freely available, click here to access the full text/PDF

Share the Knowledge